SI2411535T1 - Biooznačevalci za ovrednotenje odziva periferne nevropatije na zdravljenje z inhibitorjem proteazoma - Google Patents

Biooznačevalci za ovrednotenje odziva periferne nevropatije na zdravljenje z inhibitorjem proteazoma

Info

Publication number
SI2411535T1
SI2411535T1 SI201030988T SI201030988T SI2411535T1 SI 2411535 T1 SI2411535 T1 SI 2411535T1 SI 201030988 T SI201030988 T SI 201030988T SI 201030988 T SI201030988 T SI 201030988T SI 2411535 T1 SI2411535 T1 SI 2411535T1
Authority
SI
Slovenia
Prior art keywords
biomarkers
treatment
peripheral neuropathy
proteasome inhibitor
assessing peripheral
Prior art date
Application number
SI201030988T
Other languages
English (en)
Inventor
Nadine Cohen
Reyna Favis
Qingqin Li
Deborah Ricci
Yu Sun
De Velde Helgi Van
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of SI2411535T1 publication Critical patent/SI2411535T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI201030988T 2009-03-24 2010-03-24 Biooznačevalci za ovrednotenje odziva periferne nevropatije na zdravljenje z inhibitorjem proteazoma SI2411535T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16284809P 2009-03-24 2009-03-24
PCT/US2010/028459 WO2010111361A1 (en) 2009-03-24 2010-03-24 Biomarkers for assessing peripheral neuropathy response to treatment with a proteasome inhibitor
EP10712629.4A EP2411535B1 (en) 2009-03-24 2010-03-24 Biomarkers for assessing peripheral neuropathy response to treatment with a proteasome inhibitor

Publications (1)

Publication Number Publication Date
SI2411535T1 true SI2411535T1 (sl) 2015-08-31

Family

ID=42340761

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201030988T SI2411535T1 (sl) 2009-03-24 2010-03-24 Biooznačevalci za ovrednotenje odziva periferne nevropatije na zdravljenje z inhibitorjem proteazoma

Country Status (14)

Country Link
US (1) US9605317B2 (sl)
EP (1) EP2411535B1 (sl)
JP (1) JP5775064B2 (sl)
AU (1) AU2010229988B9 (sl)
CA (1) CA2756193A1 (sl)
DK (1) DK2411535T3 (sl)
ES (1) ES2546879T3 (sl)
HR (1) HRP20150948T1 (sl)
HU (1) HUE027639T2 (sl)
PL (1) PL2411535T3 (sl)
PT (1) PT2411535E (sl)
SI (1) SI2411535T1 (sl)
SM (1) SMT201500205B (sl)
WO (1) WO2010111361A1 (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120295256A1 (en) * 2011-05-18 2012-11-22 Genovive Llc Weight management genetic test systems and methods
CN109468388A (zh) * 2018-12-25 2019-03-15 北京北基医学检验实验室有限公司 一种扩增与运动能力相关基因的引物组及检测试剂盒
CN109750097A (zh) * 2019-01-25 2019-05-14 济南市第四人民医院 一种早期评估紫杉烷类药物化疗不良反应风险的诊断试剂盒
US20220133656A1 (en) * 2019-02-27 2022-05-05 Vanderbilt University Methods of treating trigeminal nerve pain
CN110951855B (zh) * 2019-12-04 2023-02-03 深圳先进技术研究院 缺血性脑卒中溶栓治疗后出血转化风险评估相关基因序列的芯片及其试剂盒
CN110904219B (zh) * 2019-12-24 2023-04-18 广州市妇女儿童医疗中心 Myh9及ctla4基因多态性位点在指导肾病综合征患儿使用他克莫司中的应用
CN110923310B (zh) * 2019-12-24 2023-04-18 广州市妇女儿童医疗中心 用于指导肾病综合征cyp3a5表达型患儿使用他克莫司的多态性位点
CN113528661A (zh) * 2021-02-22 2021-10-22 北京市理化分析测试中心 一种扩增ctla4基因snp位点用引物、检测试剂盒和应用
CN114712511A (zh) * 2022-04-20 2022-07-08 南通大学 Hap1在筛选神经病理性疼痛治疗药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
CA2435146C (en) * 2001-01-25 2011-03-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Formulation of boronic acid compounds
KR100653990B1 (ko) 2004-12-29 2006-12-05 주식회사 하이닉스반도체 포토마스크 데이터베이스 패턴의 불량 검사 방법
JP2009518035A (ja) 2005-12-06 2009-05-07 ザ ジェネラル ホスピタル コーポレイション 疼痛感受性および慢性化に関する診断法およびテトラヒドロビオプテリン関連障害に関する診断法
JP2010502205A (ja) * 2006-09-08 2010-01-28 ヨハン ヴォルフガング ゲーテ−ウニヴェルジテート フランクフルト アム マイン Ｇｔｐシクロヒドロラーゼ１遺伝子（ｇｃｈ１）中の疼痛保護的ハプロタイプの診断のためのｓｎｐの使用

Also Published As

Publication number Publication date
ES2546879T3 (es) 2015-09-29
AU2010229988B9 (en) 2015-09-17
US20100249065A1 (en) 2010-09-30
PT2411535E (pt) 2015-09-11
CA2756193A1 (en) 2010-09-30
EP2411535A1 (en) 2012-02-01
HRP20150948T1 (hr) 2015-10-09
PL2411535T3 (pl) 2015-11-30
US9605317B2 (en) 2017-03-28
JP2012521758A (ja) 2012-09-20
SMT201500205B (it) 2015-10-30
AU2010229988A1 (en) 2011-10-13
EP2411535B1 (en) 2015-06-17
HUE027639T2 (en) 2016-11-28
WO2010111361A1 (en) 2010-09-30
AU2010229988B2 (en) 2015-08-06
JP5775064B2 (ja) 2015-09-09
DK2411535T3 (en) 2015-07-13

Similar Documents

Publication Publication Date Title
SI2411535T1 (sl) Biooznačevalci za ovrednotenje odziva periferne nevropatije na zdravljenje z inhibitorjem proteazoma
GB2468291B (en) Monitoring a computer
HK1164489A1 (zh) 節目快捷方式
EP2498185A4 (en) VEHICLE IN-DEVICE FOR CARRYING OUT MULTIPLE APPLICATIONS
GB2470307B (en) A bed bug detecting device
EP2440936A4 (en) GROUPS OF HIGHLY SENSITIVE BIOMARKERS
EP2441278A4 (en) COMMUNICATING RESEARCH RESULTS TO A COMPUTER DEVICE
EP2494355A4 (en) IMMUNOLOGICAL ASSAY OF PCSK9
EP2457143A4 (en) DISPLAY FOR DETERMINING GESTURES
HK1187111A1 (en) A guided structured testing kit
GB2474618B (en) Predictive biomarkers
PL2653321T3 (pl) Urządzenie umożliwiające jazdę na oponie bez powietrza
EP2537133A4 (en) DESIGN ENHANCER
HK1162072A1 (en) Crystal-bezel assembly unit for a timepiece and process for assembly
ZA201104776B (en) Indicator popup
IL219834A0 (en) Melanoma specific biomarker
GB2486122A8 (en) Methods for detecting autodigestion
GB0903417D0 (en) Biomarkers
GB0915736D0 (en) Biomarkers
GB0903391D0 (en) Biomarkers
GB0919520D0 (en) Quantifying cell death
GB0912190D0 (en) Biomarker
GB0920465D0 (en) A portable display
GB0912175D0 (en) Biomarker
GB0922236D0 (en) Biomarkers